Total Funding
48
61
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
8803
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Acquired by 
Sorrento Therapeutics
Henry Ji: Chief Executive Officer and PresidentPast Role: SmartPharm Therapeutics, President and CEO
Stephen Ma: CFO & COO
About the Company
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products with more efficient and effective delivery solutions for the treatment of pain.
